Wu, Guiye – Trademark Portfolio

Entity Type: 01

Wu, Guiye owns a portfolio of 5 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), including well-known marks such as BOOPPIO, RUMOOKI, and KULAMATA. Of these, 3 are registered. The portfolio spans 3 Nice Classification classes, led by Class 20 (Furniture) and Class 10 (Medical Apparatus). Headquartered in Quanzhou, Fujian.

No. 2 Yangzhong, Pantian Village,

Gande Town, Anxi County,

Quanzhou, Fujian 362431 , CN

5 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

BOOPPIO
BOOPPIO
Registered 2022
KULAMATA
KULAMATA
Registered 2022
RUMOOKI
RUMOOKI
Registered 2022

Trademark Classifications

Wu, Guiye's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

20
Furniture (2 filings)

Furniture, mirrors, picture frames; goods of wood, cork, reed, cane, wicker

10
Medical Apparatus (2 filings)

Surgical, medical, dental and veterinary apparatus and instruments

24
Fabrics (1 filing)

Textiles and textile goods; bed covers; table covers

Frequently Asked Questions

How many trademarks does Wu, Guiye have?

Wu, Guiye has 5 U.S. trademarks filed with the USPTO. Of these, 3 registered.

What trademark classes does Wu, Guiye file in?

Wu, Guiye files trademarks across 3 Nice Classification classes. The most active classes are Class 20 (Furniture), Class 10 (Medical Apparatus), Class 24 (Fabrics). Class 20 covers furniture, mirrors, picture frames; goods of wood, cork, reed, cane, wicker.

What are Wu, Guiye's most well-known trademarks?

Wu, Guiye's registered trademark portfolio includes well-known marks such as BOOPPIO, RUMOOKI, and KULAMATA. These are among 3 currently registered trademarks in the portfolio.

What is Wu, Guiye's trademark registration success rate?

Wu, Guiye has a 100% trademark registration rate, with 3 out of 3 resolved applications resulting in successful registration. Currently, 0 applications are pending review.